The progression through the cell cycle phases is driven by cyclin-dependent kinases and cyclins as their regulatory subunits. As nuclear protein, the cell cycle inhibitor p21/CDKN1A arrests the cell cycle at the growth phase G1 by inhibiting the activity of cyclin-dependent kinases. The G1 phase correlates with increased cell size and cellular productivity. Here, we applied an optogenetic approach to control the subcellular localization of p21 and its nuclear functions. To generate light-controllable p21, appropriate fusions with the blue light switch cryptochrome 2/CIBN and the AsLOV-based light-inducible nuclear localization signal, LINuS, were used. Both systems, p21-CRY2/CIB1 and p21-LINuS, increased the amounts of cells arrested in the G1 phase correlating with the increased cell-specific productivity of the reporter-protein-secreted alkaline phosphatase. Varying the intervals of blue LED light exposure and the light dose enable the fine-tuning of the systems. Light-controllable p21 implemented in producer cell lines could be applied to steer the uncoupling of cell proliferation and cell cycle arrest at the G1 phase optimizing the production of biotherapeutic proteins.
5 December 2024 in Applied Microbiology and Biotechnology
Research for biopharmaceutical production processes with mammalian cells steadily aims to enhance the cell-specific productivity as a means for optimizing total productivities of bioreactors. Whereas current technologies such as pH, temperature, and osmolality shift require modifications of the cultivation medium, the use of optogenetic switches in recombinant producer cells might be a promising contact-free alternative. However, the proper application of optogenetically engineered cells requires a detailed understanding of basic cellular responses of cells that do not yet contain the optogenetic switches. The knowhow of ideal light exposure to enable the optimum use of related approaches is missing so far. Consequently, the current study set out to find optimum conditions for IgG1 producing Chinese hamster ovary (CHO) cells which were exposed to blue LED light. Growth characteristics, cell-specific productivity using enzyme-linked immunosorbent assay, as well as cell cycle distribution using flow cytometry were analyzed. Whereas too harsh light exposure causes detrimental growth effects that could be compensated with antioxidants, a surprising boost of cell-specific productivity by 57% occurred at optimum high light doses. The increase coincided with an increased number of cells in the G1 phase of the cell cycle after 72 h of illumination. The results present a promising new approach to boost biopharmaceutical productivity of mammalian cells simply by proper light exposure without any further optogenetic engineering. Key points: • Blue LED light hinders growth in CHO DP-12 cells• Antioxidants protect to a certain degree from blue light effects• Illumination with blue LED light raises cell-specific productivity
Improving cell‐specific productivity remains a central objective in biopharmaceutical manufacturing. In this study, the effect of blue light illumination on IgG1‐producing CHO DP‐12 cells was systematically evaluated across batch, fed‐batch, and perfusion cultivations in controlled 3 L bioreactor systems. Blue light exposure consistently increased cell‐specific monoclonal antibody productivity by approximately 30%–37% in batch and fed‐batch processes and up to 13% overall (and up to 125% in specific phases) in perfusion cultures, despite variable effects on growth and viable cell density. Metabolic characterization revealed increased lactate production under illumination, while glucose consumption remained almost unchanged. Intracellular metabolite analysis showed no consistent perturbations in central carbon metabolism but indicated generally reduced amino acid pools, suggesting enhanced utilization for protein synthesis. Although adenylate energy charge was slightly reduced in illuminated cultures, values remained within physiologically functional ranges. Notably, redox analysis based on glutathione ratios and redox potential pointed to a more reduced intracellular environment under blue light, contradicting the initial hypothesis of light‐induced oxidative stress. Overall, the data indicate that blue light illumination induces a robust metabolic phenotype characterized by enhanced productivity without detrimental metabolic stress. Given its compatibility with standard bioreactor operation and its non‐invasive nature, optimized blue light exposure represents a promising strategy for process intensification in industrial biopharmaceutical production.